VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25626N0023
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,052
Award facts
- Contract value 100% obligated
- $15,051.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation received a Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network 16 (VISN 16) for point-of-care whole blood glucose testing equipment and supplies. The contract, effective October 1, 2025, carries a ceiling value of $15,051.92 under firm fixed-price terms and is scheduled for ultimate completion by September 30, 2026. The award represents a child contract under the parent GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII), and will be performed at Roche's facility in Castleton, Indiana. This award was made without set-aside designation, reflecting open competition in the federal marketplace.
The award supports the Department of Veterans Affairs' clinical laboratory operations through supply of glucose monitoring solutions, consistent with VISN 16's healthcare delivery mission. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, serves as a primary supplier of diagnostic solutions across the VA system, maintaining an extensive portfolio of federal contracts with multiple VISNs and other federal health agencies. The company's broader federal footprint includes substantial contracts with the Defense Health Agency, Centers for Disease Control and Prevention, and National Institutes of Health, positioning it as a key vendor for advanced diagnostic capabilities across military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract 36C25626N0023?
36C25626N0023 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C25626N0023 worth?
The government has obligated $15,052 on 36C25626N0023.
Is contract 36C25626N0023 an order under another contract?
Yes. 36C25626N0023 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25626N0023 competed?
The extent of competition for 36C25626N0023 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award